Full Text View
Tabular View
No Study Results Posted
Related Studies
Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus
This study has been completed.
Study NCT00042523   Information provided by National Institutes of Health Clinical Center (CC)
First Received: July 31, 2002   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Systemic Lupus Erythematosus
Additional conditions recognized in this trial
Cognition Disorders
Lupus Erythematosus, Systemic
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Immune System Diseases
Mental Disorders
Additional drug interventions recognized in this trial
Antibodies
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services